Norbert G. Riedel - Jan 3, 2025 Form 4 Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Role
Director
Signature
/s/ James R. Gruber
Stock symbol
ETON
Transactions as of
Jan 3, 2025
Transactions value $
$373,842
Form type
4
Date filed
1/6/2025, 04:22 PM
Previous filing
Aug 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETON Common Stock Options Exercise $98.1K +27.4K +45.86% $3.58 87.1K Jan 3, 2025 Direct
transaction ETON Common Stock Options Exercise $189K +50K +57.38% $3.78 137K Jan 3, 2025 Direct
transaction ETON Common Stock Options Exercise $86.8K +25K +18.23% $3.47 162K Jan 3, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETON Employee Stock Option (Right to Buy) Options Exercise $0 -27.4K -100% $0.00 0 Jan 3, 2025 Common Stock 27.4K $3.58 Direct
transaction ETON Employee Stock Option (Right to Buy) Options Exercise $0 -50K -100% $0.00 0 Jan 3, 2025 Common Stock 50K $3.78 Direct
transaction ETON Employee Stock Option (Right to Buy) Options Exercise $0 -25K -100% $0.00 0 Jan 3, 2025 Common Stock 25K $3.47 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

The reporting person has authorized and designated the named person to file this Form 4 on the reporting person's behalf for indefinite duration.